Company News in the Life Science Industry

»

Reset 

HEXO to begin trading on the NYSE American

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

First Patient Dosed in Phase 1 Clinical Trial Evaluating Neoepitopes Formulated in IMV’s DPX Delivery Platform in Ovarian Cancer Patients

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  IMV Inc.

Lexicon Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Review Sotagliflozin New Drug Application for the Treatment of Type 1 Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  LEXICON PHARMACEUTICALS, INC.

Moleculin Announces Dr. James L. Abbruzzese, Chief of Medical Oncology Division at Duke University, Joins Science Advisory Board

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Moleculin Biotech, Inc.

ProMIS Neurosciences to Participate in NobleCon15 and CanTech Investment Conferences

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  ProMIS Neurosciences, Inc.

Ossur Hf : Q4&FY 2018 Results - Conference call Tuesday 5 February at 9:00 CET

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Össur Nordic AB | Össur Germany | Össur Americas, Inc.

American Postal Workers Union Health Plan Selects Inovalon ONE® Platform

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Inovalon

Canopy Rivers Appoints Former OMERS Venture Capital Specialist as President

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Quotient Limited to Report Fiscal Third Quarter 2019 Financial Results and Host Conference Call

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  QUOTIENT LIMITED

Progressive Care Releases Open Letter to Shareholders

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Wellness Matrix Group To Initiate State-of-the-Art Wellness Model Program

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Rafael Pharmaceuticals to Present Plan for Phase 3 Trial (AVENGER 500) of devimistat (CPI-613®) in Combination with Modified FOLFIRINOX as a First Line Treatment for Metastatic Pancreatic Cancer at 2019 Gastrointestinal Cancers Symposium

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Geron Appoints Vice President, Pharmacovigilance and Drug Safety

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Geron Corporation

RedHill Biopharma Announces Fifth U.S. Patent Covering TALICIA® for H. pylori Infection

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  RedHill Biopharma Ltd.

AMAG Pharmaceuticals Completes Acquisition of Perosphere Pharmaceuticals

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  AMAG Pharmaceuticals, Inc.

Gala Pharmaceutical to Present at World Cbd Expo

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Organovo Holdings, Inc.

Abattis Removed From BCSC Temporary Order

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Abattis Bioceuticals Corporation

Agritek Holdings, Inc. Announces December Sales of Approximately 2,000 MD Vapes Units to Florida Market With New White Label Deals for Customized CBD and THC Formulas to Top Colorado and Puerto Rico Retail Dispensaries

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019

Hemostemix Provides Highlights of 2018 Accomplishments

Read more ››
By: Nasdaq / GlobenewsWire - 17 Jan 2019
Related companies:  Hemostemix Inc.
«  1  2  3  4  5 6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies